Robert B. Schulz

Robert B. Schulz is a Managing Director of Concord and a member of Concord’s Investment Committee.

Mr. Schulz has 25 years of healthcare private equity experience, in addition to 13 years of investment banking and general venture capital experience. Prior to joining Concord in 2022, Mr. Schulz co-founded CB Health Ventures and Health Enterprise Partners in 1997 and 2006 respectively. Previously, Mr. Schulz was the President and Chief Operating Officer of Harris & Harris Group, a publicly traded venture capital fund, and spent 10 years as an investment banker with The First Boston Corporation (now Credit Suisse). As a Chemical Engineer, Mr. Schulz worked for Chevron Research Company, Exxon Research and Engineering and DuPont.

Mr. Schulz received a BS and MS in Chemical Engineering from Massachusetts Institute of Technology and an MBA in Finance and Accounting from Columbia Business School.